LM-4108

HY-123639

LM-4108

LM-4108 (N-(2-Phenylethyl)-indomethacin amide) is a selective and orally active COX-2 inhibitor with an IC50 of 0.06 μM for purified human COX-2. LM-4108 shows anti-inflammatory activity and may be effective in prevention of cancer. Half-lives for the disappearance of 10 μM LM-4108 in rat, human, and mouse liver microsomes were 11 min, 21 min, and 51 min, respectively[1].

118.24 €

HY-101686

LM-1484

LM-1484 is an antagonist of CysLT1 receptor and displays a higher affinity for 3H-LTC4 sites.

8764.04 €

MBS5766989-5mg

LM-1484

1351.62 €

HY-100673

LM22A-4

LM22A-4 is a specific agonist of tyrosine kinase receptor B, used for neurological disease research.

493.58 €

MBS5758457-100mg

LM22A-4

860.75 €

MBS5758457-10mg

LM22A-4

401.75 €